EIF4E anticorps (C-Term)
Aperçu rapide pour EIF4E anticorps (C-Term) (ABIN633255)
Antigène
Voir toutes EIF4E AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- EIF4 E antibody was raised against the C terminal of EIF4
-
Purification
- Affinity purified
-
Immunogène
- EIF4 E antibody was raised using the C terminal of EIF4 corresponding to a region with amino acids TECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EIF4E Blocking Peptide, (ABIN5613341), is also available for use as a blocking control in assays to test for specificity of this EIF4E antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EIF0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))
-
Autre désignation
- EIF4E
-
Sujet
- All eukaryotic cellular mRNAs are blocked at their 5-prime ends with the 7-methylguanosine cap structure, m7GpppX (where X is any nucleotide). This structure is involved in several cellular processes including enhanced translational efficiency, splicing, mRNA stability, and RNA nuclear export.
-
Poids moléculaire
- 25 kDa (MW of target protein)
-
Pathways
- BCR Signaling
Antigène
-